Monoamine oxidase-B inhibition: a comparison of in vivo and ex vivo measures of reversible effects
- 1 October 1988
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 74 (3), 141-148
- https://doi.org/10.1007/bf01244780
Abstract
A behavioural test involving potentiation of the effects of an acute injection of β-phenylethylamine (10 mg kg−1 i.p.) was used to assess the time-course of type-B MAO inhibition after administration of (−)deprenyl (5 mg kg−1 i.p.) and of MD 240928 (20 mg kg−1 i.p.) respectively. Potentiation of the effects of β-phenylethylamine was observed 1 h after injection of (−)deprenyl or MD 240928. This effect was still evident 120 h after administration of (−)deprenyl but not 24 h after administration of MD 240928. Comparisons of ex vivo estimates of MAO activity yielded a corresponding time-course for the recovery of this enzyme. The extent of MAO inhibition required for potentiation of the effects of β-phenylethylamine was inferred from a comparison of the behavioural test results and the ex vivo MAO activity observed after (−)deprenyl administration. These comparisons indicate a significant underestimation of MD 240928-induced MAO inhibition using ex vivo measures. This underestimation is interpreted as evidence fordilution effects in the ex vivo assay of MAO inhibition. The potentiation of effects of β-phenylethylamine under the present conditions is proposed as a useful and simple test for effects of reversible type-B MAO inhibitors.Keywords
This publication has 8 references indexed in Scilit:
- Phenylethylamine-induced stereotypies in the rat: a behavioral test system for assessment of MAO-B inhibitorsPsychopharmacology, 1984
- Selective inhibitors of monoamine oxidase A and B: Biochemical, pharmacological, and clinical propertiesMedicinal Research Reviews, 1984
- Different stereoselective inhibition of monoamine oxidase-B by the R- and S-enantiomers of MD 780236Journal of Pharmacy and Pharmacology, 1983
- The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-{4-[(3-chlorophenyl)methoxy]phenyl}-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactionsBiochemical Journal, 1982
- A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to (+)- amphetamine, p-methoxy amphetamine and harmalineBiochemical Pharmacology, 1980
- The effects of 5-HT uptake- and MAO-inhibitors on l-5-HTP-induced excitation in ratsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1980
- Activation of platelet monoamine oxidase by plasma in the humanLife Sciences, 1979
- Relations Between the Degree of Monoamine Oxidase Inhibition and Some Psychopharmacological Responses to Monoamine Oxidase Inhibitors in RatsPublished by Wiley ,1976